Quick Dispatch:
Your foxo4-dri senolytic peptide human trial 2024 The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your foxo4-dri senolytic peptide human trial 2024 The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI ships.
Need Help?
Questions about foxo4-dri senolytic peptide human trial 2024 The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for foxo4-dri senolytic peptide human trial 2024 The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI in your area.
Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis
28.94
Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis
21.43
Buy FOXO4-DRI (Proxofim)
28.34
FOXO4-DRI (Proxofim)
22.49
Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment
26.44
FOXO4-DRI UK | Senolytic Peptide Research
27.12
Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells
22.29
